Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Neonatal abstinence syndrome after methadone or buprenorphine exposure.

Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G.

N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.

2.

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L.

Drug Alcohol Depend. 2005 Jul;79(1):1-10.

PMID:
15943939
3.

Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.

Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M.

Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23.

PMID:
25183042
4.

Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.

Metz V, Jagsch R, Ebner N, Würzl J, Pribasnig A, Aschauer C, Fischer G.

Hum Psychopharmacol. 2011 Aug;26(6):412-21. doi: 10.1002/hup.1224. Epub 2011 Aug 8.

5.

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.

Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:53-62. doi: 10.1111/j.1360-0443.2012.04039.x.

7.

Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.

Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G.

Addiction. 2011 Jul;106(7):1355-62. doi: 10.1111/j.1360-0443.2011.03440.x. Epub 2011 May 12.

8.

Neonatal neurobehavior effects following buprenorphine versus methadone exposure.

Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fischer G.

Addiction. 2012 Nov;107 Suppl 1:63-73. doi: 10.1111/j.1360-0443.2012.04040.x.

9.

Buprenorphine and naloxone compared with methadone treatment in pregnancy.

Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J.

Obstet Gynecol. 2015 Feb;125(2):363-8. doi: 10.1097/AOG.0000000000000640.

PMID:
25569005
10.

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:45-52. doi: 10.1111/j.1360-0443.2012.04038.x.

11.

Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Pritham UA, Paul JA, Hayes MJ.

J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):180-90. doi: 10.1111/j.1552-6909.2011.01330.x. Epub 2012 Feb 29.

12.

Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.

Noormohammadi A, Forinash A, Yancey A, Crannage E, Campbell K, Shyken J.

Ann Pharmacother. 2016 Aug;50(8):666-72. doi: 10.1177/1060028016648367. Epub 2016 May 19. Review.

PMID:
27199497
13.

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Kakko J, Heilig M, Sarman I.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.

PMID:
18355989
14.

Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.

Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P.

Am J Epidemiol. 2014 Oct 1;180(7):673-86. doi: 10.1093/aje/kwu190. Epub 2014 Aug 22. Review.

PMID:
25150272
15.

Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.

Jones HE, Dengler E, Garrison A, O'Grady KE, Seashore C, Horton E, Andringa K, Jansson LM, Thorp J.

Drug Alcohol Depend. 2014 Jan 1;134:414-417. doi: 10.1016/j.drugalcdep.2013.11.006. Epub 2013 Nov 16.

16.

Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.

Colombini N, Elias R, Busuttil M, Dubuc M, Einaudi MA, Bues-Charbit M.

Pharm World Sci. 2008 Jun;30(3):227-34. Epub 2007 Nov 16.

PMID:
18008179
17.

Maintenance agonist treatments for opiate-dependent pregnant women.

Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M.

Cochrane Database Syst Rev. 2013 Dec 23;(12):CD006318. doi: 10.1002/14651858.CD006318.pub3. Review.

PMID:
24366859
18.

Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.

Debelak K, Morrone WR, O'Grady KE, Jones HE.

Am J Addict. 2013 May-Jun;22(3):252-4. doi: 10.1111/j.1521-0391.2012.12005.x.

PMID:
23617867
19.

Management of neonatal abstinence syndrome in neonates born to opioid maintained women.

Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K, Fischer G.

Drug Alcohol Depend. 2007 Mar 16;87(2-3):131-8. Epub 2006 Sep 26.

PMID:
17000060
20.

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.

Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G.

Addiction. 2012 Nov;107 Suppl 1:5-27. doi: 10.1111/j.1360-0443.2012.04035.x. Review.

Supplemental Content

Support Center